Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric citrate vs sevelamer carbonate in CKD dialysis patients with hyperphosphatemia
CTR20192200Phase 3Active
- Sponsor
- Jiangsu Aosaikang Pharmaceutical Co., Ltd.
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ferric citrate in hyperphosphatemia in chronic kidney disease, sponsored by Jiangsu Aosaikang Pharmaceutical Co., Ltd.. Started Nov 2019; status: active.
02
Drugs
ferric citrate
03
Conditions
hyperphosphatemia in chronic kidney disease
Beyond the preview
Go deeper on CTR20192200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192200.